A pan-cancer investigation reveals that TPX2 promotes tumor progression, signals poor patient survival, and predicts reduced response to anti-PD-1 immunotherapy.
A retrospective cohort study in Ethiopia found that under-five children with severe pneumonia typically recovered in a median of three ...
A single-arm exploratory study reports an 88.2 percent 12-week objective response rate and preliminary two-year survival estimates for nimotuzumab added ...
A Hamburg registry study of 576 advanced ovarian cancer patients found that complete surgical clearance was associated with lower mortality ...
An exploratory Korean cohort study found higher home and community-based service volume was associated with lower long-term care facility transition ...
A retrospective cohort of 332 treatment-experienced adults with HIV at a Nigerian hospital found that nearly half experienced at least ...
A population-based study of 325 nonmetastatic soft tissue sarcoma cases in the Veneto region found five-year overall survival of 73.2%, ...
A letter in the Egyptian Journal of Neurosurgery argues that guarantee-time bias may have inflated the apparent survival benefit of ...
A retrospective cohort study of 391 neonates in South Ethiopia found a mortality rate of 12.2 per 1,000 neonate-days and ...
A single-center retrospective study of 357 patients links prior angioplasty count, lesion length, post-procedure blood flow and red blood cell ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
